Suppr超能文献

格拉斯哥动脉瘤评分:能否预测腹主动脉瘤腔内修复术后的长期死亡率?

Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?

机构信息

Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.

Department of Cardiovascular Surgery, VM Medicalpark Hospital, Ankara, Turkey.

出版信息

BMC Cardiovasc Disord. 2021 Nov 19;21(1):551. doi: 10.1186/s12872-021-02366-y.

Abstract

BACKGROUND

To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA).

METHODS

A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier.

RESULTS

The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p < 0.001). The area under the ROC curve for GAS was 0.682 and the GAS cut-off value was 77.5 (specificity 64%, p < 0.001). The mortality rates in patients with GAS < 77.5 and GAS > 77.5 were: 12.8% and 24.8% respectively (p = 0.014). Every 10 point increase in GAS resulted in approximately a 2 fold increase in risk of long-term mortality (OR: 1.8, 95% CI 1.3-2.5; p < 0.001). Five year survival rates in patients with GAS < 77.5 and > 77.5 were 75.7% and 61.7%, respectively (p = 0.013).

CONCLUSIONS

The findings of our study suggests that an increase in GAS score may predict long-term mortality. In addition, the mortality rates in patients above the GAS cut-off value almost doubled compared to those below. Furthermore, the presence of a past history of cancer resulted in a 2.5 fold increase in long-term mortality risk. Addition of cancer to the GAS scoring system may be considered in future studies. Further studies are necessary to consolidate these findings.

摘要

背景

评估格拉斯哥动脉瘤评分(GAS)在预测接受腹主动脉瘤腔内修复术(EVAR)治疗的患者长期死亡率和生存的价值。

方法

这是一项回顾性单中心研究,纳入了 2013 年 1 月至 2021 年期间接受 EVAR 治疗的 257 例非破裂性腹主动脉瘤患者。比较了幸存者(第 1 组)和长期死亡率(第 2 组)组之间的 GAS 评分。采用 Cox 回归分析确定晚期死亡率的独立预测因素。使用接收者操作特征曲线(ROC)分析确定 GAS 值的最佳截断值,以确定其对晚期死亡率的影响。使用 Kaplan-Meier 进行生存分析。

结果

该研究纳入了 257 例平均年龄 69.75±7.75(46-92)岁、因腹主动脉瘤接受 EVAR 的患者。平均随访时间为 18.98±22.84 个月(0-88)。在长期随访中,有 45 例(17.8%)发生死亡。有癌症既往史的患者发生长期死亡的风险增加 2.5 倍(OR:2.52,95%CI 1.10-5.76;p=0.029)。与第 1 组相比,第 2 组的 GAS 值更高(81.02±10.33 比 73.73±10.46;p<0.001)。GAS 的 ROC 曲线下面积为 0.682,GAS 截断值为 77.5(特异性 64%,p<0.001)。GAS<77.5 和 GAS>77.5 的患者死亡率分别为 12.8%和 24.8%(p=0.014)。GAS 每增加 10 分,长期死亡风险增加约 2 倍(OR:1.8,95%CI 1.3-2.5;p<0.001)。GAS<77.5 和 GAS>77.5 的患者 5 年生存率分别为 75.7%和 61.7%(p=0.013)。

结论

本研究结果表明,GAS 评分的升高可能预测长期死亡率。此外,高于 GAS 截断值的患者死亡率几乎是低于该值的患者的两倍。此外,癌症既往史使长期死亡风险增加 2.5 倍。在未来的研究中,可以考虑将癌症纳入 GAS 评分系统。需要进一步的研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c379/8603579/0e181e4b170c/12872_2021_2366_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验